• Home
  • Les Laboratoires Medis

Les Laboratoires Medis

About Les Laboratoires Medis

Les Laboratoires Medis is a limited company under Tunisian law with a mandate to manufacture and market various generic medications. It is founded in 1995 under the vision of Dr Lassaad Boujbel to create a quality manufacturing facility to serve the Tunisian people and the region.
Les Laboratoires Medis started on February 2000 and currently has a broad portfolio of over 250 quality product...

Read more Show less
Categories
more categories Show less
  • Country/Region:
    Tunisia
  • On CPHI since:
    2018
Contact info
Show contact info Hide contact info

Products from Les Laboratoires Medis (3)

  • BORTESOMIB NEAPOLIS (bortezomib)

    Product BORTESOMIB NEAPOLIS (bortezomib)

    Bortezomib NEAPOLIS for Injection is an antineoplastic agent available for intravenous injection (IV) use only.

    Each single dose vial contains 3.5 mg of Bortezomib as a sterile lyophilized powder
  • ENOXA (enoxaparin sodium)

    Product ENOXA (enoxaparin sodium)

    ENOXA is a Low Molecular Weight Heparin, in a prefilled seringe. It is the first product in sales in Tunisia
  • EPOMAX 2000 (RECOMBINANT HUMAN ERYTHROPOEITIN ALPHA? 2000 UI / 1 ml)

    Product EPOMAX 2000 (RECOMBINANT HUMAN ERYTHROPOEITIN ALPHA? 2000 UI / 1 ml)

    After granting the Marketing Authorization of THE FIRST Human Recombinant alpha Erythropoietin (EPO), MédiS becomes the FIRST Tunisian pharmaceutical company to produce and market its biosimilar EPO commercially appointed as EPOMAX®.

Les Laboratoires Medis Resources (1)